Resmed Inc. Stock
Resmed Inc. Stock
We can see a decrease in the price for Resmed Inc.. Compared to yesterday it has lost -€2.200 (-1.120%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Resmed Inc..
With a target price of 258 € there is a positive potential of 32.99% for Resmed Inc. compared to the current price of 194.0 €.
Pros and Cons of Resmed Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | -1.120% | 5.780% | 14.759% | -20.622% | -6.954% | 16.973% | -16.845% |
| Veeva Systems A | -3.200% | 5.720% | 24.564% | -10.796% | 10.026% | 19.343% | -22.792% |
| Boston Scientific | -0.020% | 5.052% | 19.605% | -49.989% | -44.951% | -4.801% | 19.239% |
| Waters Corp. | -0.720% | 1.250% | 8.065% | 40.536% | 8.725% | 35.000% | 3.605% |
Comments
ResMed (RMD) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $276.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $266.00 price target by KeyCorp. They now have an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat